Clinical Trial Update: Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effects of blonanserin on social and cognitive functions in patients with first-episode schizophrenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia First-episode

Drugs mentioned

• blonanserin (blonanserin)

Snippet

Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd. | Conditions: First Episode Schizophrenia, Social Function | Phase 4 | Status: TERMINATED